Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.47 |
| ▸ | PAM | P19021 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 3/20 | 0.44 |
| ▸ | NAAA | Q02083 | 2/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7108908 | 1.00 | IDO1 (0.52) | IDO1SIGMAR1PAMMEN1KMT2A | |
| SCHEMBL28661525 | 0.89 | HRH3 (0.49) | IDO1SIGMAR1PAMMEN1KMT2A | |
| SCHEMBL10889742 | 0.87 | IDO1 (0.48) | IDO1SIGMAR1PAMMEN1KMT2A | |
| SCHEMBL7110889 | 0.87 | IDO1 (0.48) | IDO1SIGMAR1PAMMEN1KMT2A | |
| SCHEMBL4372992 | 0.85 | MAOB (0.56) | IDO1PAMMEN1KMT2AMAOB | |
| SCHEMBL9762776 | 0.83 | IDO1 (0.42) | IDO1SIGMAR1PAMMEN1KMT2A | |
| SCHEMBL7939387 | 0.83 | IDO1 (0.56) | IDO1SIGMAR1PAMMAOBHTR2A | |
| SCHEMBL10430031 | 0.83 | IDO1 (0.56) | IDO1SIGMAR1PAMMAOBHTR2A | |
| SCHEMBL7568412 | 0.83 | IDO1 (0.56) | IDO1SIGMAR1PAMMAOBHTR2A | |
| SCHEMBL15907605 | 0.83 | MEN1 (0.61) | IDO1SIGMAR1PAMMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11691958-B2 | Enantioselective cross dehydrogenative coupling reactions and compounds synthesized by the reactions | NORTHWESTERN UNIVERSITY (US) | 2023-07-04 | — | — | US | disclosed |
| US-20220259171-A1 | ENANTIOSELECTIVE CROSS DEHYDROGENATIVE COUPLING REACTIONS AND COMPOUNDS SYNTHESIZED BY THE REACTIONS | NORTHWESTERN UNIVERSITY (US) | 2022-08-18 | — | — | US | disclosed |
| US-11174238-B2 | Enantioselective cross dehydrogenative coupling reactions and compounds synthesized by the reactions | NORTHWESTERN UNIVERSITY (US) | 2021-11-16 | — | — | US | disclosed |
| US-20200181106-A1 | ENANTIOSELECTIVE CROSS DEHYDROGENATIVE COUPLING REACTIONS AND COMPOUNDS SYNTHESIZED BY THE REACTIONS | NORTHWESTERN UNIVERSITY (US) | 2020-06-11 | — | — | US | disclosed |
| EP-0794218-B1 | Polycarbonate resin composition stabilized against radiation | MITSUBISHI ENG PLASTICS CORP (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-6040367-A | EXCELLENT RESISTANCE TO AN IONIZING RADIATION, IN WHICH HETEROCYCLIC COMPOUND CONTAINING OXYMETHYLENE UNITS | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5948838-A | 0.01 TO 5 PARTS BY WEIGHT OF A COMPOUND CONTAINING OXYMETHYLENE UNIT | MITSUBISHI ENGINEERING-PLASTICS CORP. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0794218-A2 | Polycarbonate resin composition stabilized against radiation | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 1997-09-10 | — | — | EP | disclosed |
| US-5508412-A | USED IN FORMATION OF UNSATURATED CYCLOHEXENONE OXIME ETHERS; HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-04-16 | — | — | US | disclosed |
| US-5407896-A | Herbicides | BASF AKTIENGESELLSCHAFT (DE) | 1995-04-18 | — | — | US | disclosed |
| US-5403812-A | Also containing a sulfur-containing ring; control of grasses but selective of broad-leaved and monocotyledonous crops | BASF AKTIENGESELLSCHAFT (DE) | 1995-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11691958-B2 | Enantioselective cross dehydrogenative coupling reactions and compounds synthesized by the reactions | DUOX1, DUOX2, ALDH3A1 | IDO1 763/4885SIGMAR1 3505/4885PAM 1237/4885 |
| US-20220259171-A1 | ENANTIOSELECTIVE CROSS DEHYDROGENATIVE COUPLING REACTIONS AND COMPOUNDS SYNTHESIZED BY THE REACTIONS | DUOX1, DUOX2, ALDH3A1 | IDO1 763/4885SIGMAR1 3505/4885PAM 1237/4885 |
| US-20200181106-A1 | ENANTIOSELECTIVE CROSS DEHYDROGENATIVE COUPLING REACTIONS AND COMPOUNDS SYNTHESIZED BY THE REACTIONS | DUOX1, DUOX2, ALDH3A1 | IDO1 763/4885SIGMAR1 3505/4885PAM 1237/4885 |
| US-11174238-B2 | Enantioselective cross dehydrogenative coupling reactions and compounds synthesized by the reactions | DUOX1, DUOX2, ALDH3A1 | IDO1 763/4885SIGMAR1 3505/4885PAM 1237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.